You are here:

NICE
NICE Guidance
Conditions and diseases
Blood and immune system conditions
Blood and bone marrow cancers

Ibrutinib with venetoclax for untreated chronic lymphocytic leukaemia

Technology appraisal guidance
Reference number: TA891
Published: 31 May 2023

Guidance
Tools and resources
Information for the public
Evidence
History

Evidence

Review and download supporting evidence. Includes the full guideline if available.

Supporting evidence

Evaluation report
Committee papers (PDF 8.26 MB)

Published:

31 May 2023